期刊文献+

门冬氨酸鸟氨酸与纳络酮联用治疗肝性脑病的疗效观察 被引量:2

下载PDF
导出
摘要 目的观察门冬氨酸鸟氨酸联合纳络酮治疗肝性脑病的临床疗效。方法将64例肝硬化并肝性脑病患者分为治疗组和对照组各32例,治疗组在常规治疗的基础上加门冬氨酸鸟氨酸与纳络酮静脉滴注,2周为1个疗程。结果治疗组缩短苏醒时间,总有效率87.5%,与对照组68.8%比较有统计学意义(P<0.05)。结论门冬氨酸鸟氨酸联合纳络酮治疗肝性脑病无明显不良反应,是治疗肝性脑病的一种较好方法。
作者 贲立军 徐萍
出处 《宁夏医学杂志》 CAS 2011年第2期157-158,共2页 Ningxia Medical Journal
  • 相关文献

参考文献4

二级参考文献11

  • 1陈合民.鸟氨酸—天门冬氨酸联合乳果糖治疗肝性脑病疗效观察[J].实用肝脏病杂志,2003,6(3):154-155. 被引量:12
  • 2于中麟,钱林学.乳果糖在肝病治疗中的应用[J].中华内科杂志,1996,35(1):65-65. 被引量:37
  • 3Roger F, Butterworth H. Pathophysiology of hepatic eneephalopathy: anew look at ammonia. Metabolic Brain Disease, 2002,17 (4) : 221-227.
  • 4姚光弼.临床肝胆病学.上海:上海科技出版社,2004:281-296.
  • 5Kircheis G,Wettstein M,Dahl S, et al. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis, 2002,17 (4) : 453-462.
  • 6Als-Nielsen B, Gluud LL, Gluud C. Non - absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ, 2004, 328:1046.
  • 7Katayama K. Ammonia metabolism and hepatic encephalopathy.Hepatol Res, 2004,30S: 73.
  • 8Mascarenhas R, Mobarhan S. New support for branched- chain amino acid supplementation in advanced hepatic failure. Nutr Rev, 2004, 62:33.
  • 9Als-Nielsen B, Gluud LL, Gluud C. Benzodiazepine receptor antagonists for hepatic encephalopathy. Cochrane Database Syst Rev, 2004,2:2798.
  • 10Blei A, I26rdoba J Practice Parameters Committee of the American College of Gastroenterology, Hepatic Encephalopathy. Am J Gastroenterol, 2001,96:1968.

共引文献35

同被引文献16

  • 1彭军宁.门冬氨酸鸟氨酸联合纳络酮治疗肝性脑病临床观察[J].求医问药(下半月),2013(4):131-132. 被引量:2
  • 2陈灏珠.实用内科学[M].2版.北京:人民卫生出版社,2001.
  • 3Pipili C, Polydorou A, Pantelias K, et al. Improvement of hepatic enceph_alopathy by application of peritoneal dialysis in a patient with non- end- stage renal disease[J]. Perit Dial Int, 2013, 33(2): 213.
  • 4Sharma P, Sharrna B C. Disaccharides in the treatment of hepatic eneephalopathy[J ]. Metab Brain Dis, 2013 : [ Epub ahead of print].
  • 5Kalaitzakis E, Josefsson A, Castedal M, et al. Hepatic en- cephalopathy is related to anemia and fat - free mass depletion in liver transplant candidates with cirrhosis[J ]. Scand J Gas- troenterol, 2013: [Epub ahead of print].
  • 6Hung T H, Lay C J, Chang C M, et al. The effect of infec- tions on the mortality of cirrhotic patients with hepatic en- cephalopathy [ J ]. Epidemiol Infect, 2013 : [ Epub ahead of print],.
  • 7Safonova M V, Kozlova I V, Ovsiannikova V V, et al. Hep-atic encephalopathy and colon pathology in liver cirrhosis[J ]. Eksp Klin Gastroenterol, 2012, (6) : 20.
  • 8Patidar K R, Bajaj J S. Antibiotics for the treatment of hep- atic encephalopathy [J ]. Metab Brain Dis, 2013 : [ Epub a- head of print].
  • 9Cudalbu C. In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using (1)H Magnetic Res- onance Spectroscopy[J]. Metab Brain Dis, 2012: [Epub a- head of print].
  • 10Tranah T H, Vijay G K, Ryan J M, et al. Systemic inflam- mation and ammonia in hepatic encephalopathy [ J ]. Metab Brain Dis, 2013, 28(1): 1.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部